NewsBenzingaEdwards Lifesciences reduce la previsión de ventas para el año fiscal 2026 de 6.600 millones de dólares a 6.900 millones de dólares a 6.766 millones de dólares, frente a una estimación de 6.767 millones de dólares Edwards Lifesciences reduce la previsión de ventas para el año fiscal 2026 de 6.600 millones de dólares a 6.900 millones de dólares a 6.766 millones de dólares, frente a una estimación de 6.767 millones de dólares Benzinga 2026.11.04 21:20 (GMT+0) Open on Benzinga Other news Prospect Capital Announces $200M Buyback Plan Liberty Latin America Q3 EPS $(0.42) Misses $(0.10) Estimate, Sales $1.117B Miss $1.139B Estimate 'Senate Republicans ask court to overturn ruling on EPA California vehicle emissions waiver reviews' - Reuters Sturm, Ruger & Company Announced In October That It Would Suspend Production Of A Limited Number Of Product Families; Products Represent About $25M Of Co's Total Revenues And Generate Minimal To No Profitability Here’s How Much You Would Have Made Owning Credicorp Stock In The Last 5 Years Scotiabank Maintains Sector Perform on Hecla Mining, Lowers Price Target to $20
'Senate Republicans ask court to overturn ruling on EPA California vehicle emissions waiver reviews' - Reuters
Sturm, Ruger & Company Announced In October That It Would Suspend Production Of A Limited Number Of Product Families; Products Represent About $25M Of Co's Total Revenues And Generate Minimal To No Profitability
